A new mathematical analysis strengthens concerns about the effects of the new variant on the pandemic’s course.
Tag: South Africa
Omicron Variant Reinfects People Who Have Had the Coronavirus
Evidence from South Africa, where the Omicron variant already dominates, shows a high rate of reinfection of people who have already had the coronavirus.
Omicron Variant Reinfects People Who Have Had the Coronavirus
Evidence from South Africa, where the Omicron variant already dominates, shows a high rate of reinfection of people who have already had the coronavirus.
Why Didn’t the U.S. Detect Omicron Cases Sooner?
Genomic surveillance has improved enormously in recent months, but the system has built-in delays, and blind spots remain.
Why Hasn’t the U.S. Found More Omicron Cases?
Genomic surveillance has improved enormously in recent months, but the system has built-in delays, and blind spots remain.
Vaccine Hesitancy Hurts Covid Fight in Poorer Countries
Vaccines are finally available in many African countries, but an underfunded public health system has slowed their delivery, and some people there, as well as in South Asia, are wary of taking them.
Omicron Variant, in 20 Nations, Spread Earlier Than Was Known
With evidence growing that a worrisome new coronavirus variant is highly contagious, health officials issued warnings that vulnerable people should not travel.
How 2 Flights to Europe May Have Spurred Spread of New Variant
A confounding array of Covid rules and lax enforcement of mask wearing may have sent infected passengers on two KLM flights from South Africa on to “who knows where.”
South African Company Nears License to Sell J. & J. Covid Shot Across Africa
The new agreement makes Aspen Pharmacare the first African company to market a Covid vaccine on the continent. But it stops short of allowing Aspen to make the ingredients in the vaccine.
South African Company Nears License to Sell J. & J. Covid Shot Across Africa
The new agreement makes Aspen Pharmacare the first African company to market a Covid vaccine on the continent. But it stops short of allowing Aspen to make the ingredients in the vaccine.